Abstract
Admission UHR is independently linked to unfavorable prognosis among individuals with AIS and holds promise as a simple, economical tool for early risk stratification and personalized management. Its use could support timely interventions and personalized management, contributing to improved patient outcomes and efficient allocation of healthcare resources. Prospective research is needed to validate its prognostic value and guide targeted interventions.
Affiliated Institutions
Related Publications
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Background and Purpose— The National Institutes of Health (NIH) estimates that stroke costs now exceed $45 billion per year. Stroke is the third leading cause of death and one o...
Publication Info
- Year
- 2025
- Type
- article
- Volume
- 24
- Issue
- 1
- Pages
- 381-381
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1186/s12944-025-02780-7